FAS inhibitors (FASgen/Johns Hopkins/Johnson & Johnson)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameFAS inhibitors (FASgen/Johns Hopkins/Johnson & Johnson)

Drug Alias NameFAS inhibitors (FASgen/Johns Hopkins)fatty acid synthase inhibitors (FASgen/Johns Hopkins)FASifatty acid synthase inhibitors (FASgen/Johns Hopkins/ Johnson & Johnson)FAS-093 +[8]

ClassificationSmall molecules

Mechanisms of ActionFatty acid synthase inhibitors

TargetsFatty acid synthase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFASgen Inc Johnson & Johnson

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A